Shaun Lonergan has become CEO of Nerites, which develops new wound adhesives, and has joined the company's board of directors. Most recently, he was vice president of sales, marketing, and business development for Ibis Biosciences, which was sold to Abbott Molecular in January. Prior to that, he held similar positions at 454 Life Sciences and NimbleGen Systems. Earlier, he was vice president of corporate development at Third Wave Technologies.
People in the News: Mar 17, 2009
Mar 18, 2009